APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Medicines and Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Veterinary Medicines and Vaccines Market Outlook and Growth Opportunities 2026

Report ID 17404619042 January 2026199 pages

Choose your research edition.

Industry ResearchVeterinary Medicines and Vaccines Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Medicines and Vaccines Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Veterinary Medicines and Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Medicines and Vaccines Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Medicines and Vaccines Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Veterinary Medicines and Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Veterinary Medicines and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary Medicines and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Medicines and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Veterinary Medicines and Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Veterinary Medicines and Vaccines market include Boehringer Ingelheim, Ceva, Dechra Veterinary Products, Elanco Animal Health, Meiji, Ouro Fino Saude, Parnell, Vetoquinol and Virbac, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Veterinary Medicines and Vaccines market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary Medicines and Vaccines and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Medicines and Vaccines revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Veterinary Medicines and Vaccines market.

Veterinary Medicines and Vaccines Segment by Company

Boehringer Ingelheim

Ceva

Dechra Veterinary Products

Elanco Animal Health

Meiji

Ouro Fino Saude

Parnell

Vetoquinol

Virbac

Zoetis

Bayer Animal Health

Merck Animal Health

Veterinary Medicines and Vaccines Segment by Type

Medicines

Vaccines

Veterinary Medicines and Vaccines Segment by Application

Companion Animals

Farm Animals

Veterinary Medicines and Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Veterinary Medicines and Vaccines status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Veterinary Medicines and Vaccines key companies, revenue, market share, and recent developments.

3. To split the Veterinary Medicines and Vaccines breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Veterinary Medicines and Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Veterinary Medicines and Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Veterinary Medicines and Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Medicines and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Medicines and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Medicines and Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Medicines and Vaccines industry.

Chapter 3: Detailed analysis of Veterinary Medicines and Vaccines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Veterinary Medicines and Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Veterinary Medicines and Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Veterinary Medicines and Vaccines Industry Trends Table 2. Veterinary Medicines and Vaccines Industry Drivers Table 3. Veterinary Medicines and Vaccines Industry Opportunities and Challenges Table 4. Veterinary Medicines and Vaccines Industry Restraints Table 5. Global Veterinary Medicines and Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Veterinary Medicines and Vaccines Revenue Share by Company (2021-2026) Table 7. Global Veterinary Medicines and Vaccines Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Veterinary Medicines and Vaccines Key Company Manufacturing Base & Headquarters Table 9. Global Veterinary Medicines and Vaccines Company, Product Type & Application Table 10. Global Veterinary Medicines and Vaccines Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Veterinary Medicines and Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Medicines Table 15. Significant Companies of Vaccines Table 16. Global Veterinary Medicines and Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Veterinary Medicines and Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Veterinary Medicines and Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Veterinary Medicines and Vaccines Sales Value Share by Type (2021-2026) Table 20. Global Veterinary Medicines and Vaccines Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Companion Animals Table 22. Significant Companies of Farm Animals Table 23. Global Veterinary Medicines and Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Veterinary Medicines and Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Veterinary Medicines and Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Veterinary Medicines and Vaccines Sales Value Share by Application (2021-2026) Table 27. Global Veterinary Medicines and Vaccines Sales Value Share by Application (2027-2032) Table 28. Global Veterinary Medicines and Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Veterinary Medicines and Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Veterinary Medicines and Vaccines Sales Value Share by Region (2021-2026) Table 31. Global Veterinary Medicines and Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Veterinary Medicines and Vaccines Sales Value Share by Region (2027-2032) Table 33. Global Veterinary Medicines and Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Veterinary Medicines and Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Veterinary Medicines and Vaccines Sales Value Market Share by Country (2021-2026) Table 36. Global Veterinary Medicines and Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Veterinary Medicines and Vaccines Sales Value Market Share by Country (2027-2032) Table 38. Boehringer Ingelheim Company Information Table 39. Boehringer Ingelheim Business Overview Table 40. Boehringer Ingelheim Veterinary Medicines and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Boehringer Ingelheim Veterinary Medicines and Vaccines Product Portfolio Table 42. Boehringer Ingelheim Recent Development Table 43. Ceva Company Information Table 44. Ceva Business Overview Table 45. Ceva Veterinary Medicines and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Ceva Veterinary Medicines and Vaccines Product Portfolio Table 47. Ceva Recent Development Table 48. Dechra Veterinary Products Company Information Table 49. Dechra Veterinary Products Business Overview Table 50. Dechra Veterinary Products Veterinary Medicines and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Dechra Veterinary Products Veterinary Medicines and Vaccines Product Portfolio Table 52. Dechra Veterinary Products Recent Development Table 53. Elanco Animal Health Company Information Table 54. Elanco Animal Health Business Overview Table 55. Elanco Animal Health Veterinary Medicines and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Elanco Animal Health Veterinary Medicines and Vaccines Product Portfolio Table 57. Elanco Animal Health Recent Development Table 58. Meiji Company Information Table 59. Meiji Business Overview Table 60. Meiji Veterinary Medicines and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Meiji Veterinary Medicines and Vaccines Product Portfolio Table 62. Meiji Recent Development Table 63. Ouro Fino Saude Company Information Table 64. Ouro Fino Saude Business Overview Table 65. Ouro Fino Saude Veterinary Medicines and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Ouro Fino Saude Veterinary Medicines and Vaccines Product Portfolio Table 67. Ouro Fino Saude Recent Development Table 68. Parnell Company Information Table 69. Parnell Business Overview Table 70. Parnell Veterinary Medicines and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Parnell Veterinary Medicines and Vaccines Product Portfolio Table 72. Parnell Recent Development Table 73. Vetoquinol Company Information Table 74. Vetoquinol Business Overview Table 75. Vetoquinol Veterinary Medicines and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Vetoquinol Veterinary Medicines and Vaccines Product Portfolio Table 77. Vetoquinol Recent Development Table 78. Virbac Company Information Table 79. Virbac Business Overview Table 80. Virbac Veterinary Medicines and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Virbac Veterinary Medicines and Vaccines Product Portfolio Table 82. Virbac Recent Development Table 83. Zoetis Company Information Table 84. Zoetis Business Overview Table 85. Zoetis Veterinary Medicines and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Zoetis Veterinary Medicines and Vaccines Product Portfolio Table 87. Zoetis Recent Development Table 88. Bayer Animal Health Company Information Table 89. Bayer Animal Health Business Overview Table 90. Bayer Animal Health Veterinary Medicines and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Bayer Animal Health Veterinary Medicines and Vaccines Product Portfolio Table 92. Bayer Animal Health Recent Development Table 93. Merck Animal Health Company Information Table 94. Merck Animal Health Business Overview Table 95. Merck Animal Health Veterinary Medicines and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Merck Animal Health Veterinary Medicines and Vaccines Product Portfolio Table 97. Merck Animal Health Recent Development Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Veterinary Medicines and Vaccines Product Image Figure 2. Global Veterinary Medicines and Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Veterinary Medicines and Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Medicines Image Figure 8. Vaccines Image Figure 9. Global Veterinary Medicines and Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Veterinary Medicines and Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Veterinary Medicines and Vaccines Sales Value Share by Type (2021-2032) Figure 12. Companion Animals Image Figure 13. Farm Animals Image Figure 14. Global Veterinary Medicines and Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Veterinary Medicines and Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Veterinary Medicines and Vaccines Sales Value Share by Application (2021-2032) Figure 17. Global Veterinary Medicines and Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Veterinary Medicines and Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Veterinary Medicines and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 20. North America Veterinary Medicines and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Veterinary Medicines and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Veterinary Medicines and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Veterinary Medicines and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Veterinary Medicines and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Veterinary Medicines and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 26. South America Veterinary Medicines and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Veterinary Medicines and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Veterinary Medicines and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Medicines
  • Vaccines
Applications
  • Companion Animals
  • Farm Animals
Companies covered
  • Boehringer Ingelheim
  • Ceva
  • Dechra Veterinary Products
  • Elanco Animal Health
  • Meiji
  • Ouro Fino Saude
  • Parnell
  • Vetoquinol
  • Virbac
  • Zoetis
  • Bayer Animal Health
  • Merck Animal Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Veterinary Medicines and Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Veterinary Medicines and Vaccines Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Veterinary Medicines and Vaccines Market Dynamics
  1. 2.1 Veterinary Medicines and Vaccines Industry Trends
  2. 2.2 Veterinary Medicines and Vaccines Industry Drivers
  3. 2.3 Veterinary Medicines and Vaccines Industry Opportunities and Challenges
  4. 2.4 Veterinary Medicines and Vaccines Industry Restraints
3 Veterinary Medicines and Vaccines Market by Company
  1. 3.1 Global Veterinary Medicines and Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Veterinary Medicines and Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Veterinary Medicines and Vaccines Company Ranking (2024-2026)
  4. 3.4 Global Veterinary Medicines and Vaccines Company Manufacturing Base and Headquarters
  5. 3.5 Global Veterinary Medicines and Vaccines Company Product Type and Application
  6. 3.6 Global Veterinary Medicines and Vaccines Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Veterinary Medicines and Vaccines Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Veterinary Medicines and Vaccines Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Veterinary Medicines and Vaccines Market by Type
  1. 4.1 Veterinary Medicines and Vaccines Type Introduction
  2. 4.1.1 Medicines
  3. 4.1.2 Vaccines
  4. 4.2 Global Veterinary Medicines and Vaccines Sales Value by Type
  5. 4.2.1 Global Veterinary Medicines and Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Veterinary Medicines and Vaccines Sales Value by Type (2021-2032)
  7. 4.2.3 Global Veterinary Medicines and Vaccines Sales Value Share by Type (2021-2032)
5 Veterinary Medicines and Vaccines Market by Application
  1. 5.1 Veterinary Medicines and Vaccines Application Introduction
  2. 5.1.1 Companion Animals
  3. 5.1.2 Farm Animals
  4. 5.2 Global Veterinary Medicines and Vaccines Sales Value by Application
  5. 5.2.1 Global Veterinary Medicines and Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Veterinary Medicines and Vaccines Sales Value by Application (2021-2032)
  7. 5.2.3 Global Veterinary Medicines and Vaccines Sales Value Share by Application (2021-2032)
6 Veterinary Medicines and Vaccines Regional Value Analysis
  1. 6.1 Global Veterinary Medicines and Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Medicines and Vaccines Sales Value by Region (2021-2032)
  3. 6.2.1 Global Veterinary Medicines and Vaccines Sales Value by Region: 2021-2026
  4. 6.2.2 Global Veterinary Medicines and Vaccines Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Veterinary Medicines and Vaccines Sales Value (2021-2032)
  7. 6.3.2 North America Veterinary Medicines and Vaccines Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Veterinary Medicines and Vaccines Sales Value (2021-2032)
  10. 6.4.2 Europe Veterinary Medicines and Vaccines Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Veterinary Medicines and Vaccines Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Veterinary Medicines and Vaccines Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Veterinary Medicines and Vaccines Sales Value (2021-2032)
  16. 6.6.2 South America Veterinary Medicines and Vaccines Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Veterinary Medicines and Vaccines Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Veterinary Medicines and Vaccines Sales Value Share by Country, 2025 VS 2032
7 Veterinary Medicines and Vaccines Country-level Value Analysis
  1. 7.1 Global Veterinary Medicines and Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Veterinary Medicines and Vaccines Sales Value by Country (2021-2032)
  3. 7.2.1 Global Veterinary Medicines and Vaccines Sales Value by Country (2021-2026)
  4. 7.2.2 Global Veterinary Medicines and Vaccines Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Veterinary Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Veterinary Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Veterinary Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Veterinary Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Veterinary Medicines and Vaccines Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 Ceva
  8. 8.2.1 Ceva Company Information
  9. 8.2.2 Ceva Business Overview
  10. 8.2.3 Ceva Veterinary Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ceva Veterinary Medicines and Vaccines Product Portfolio
  12. 8.2.5 Ceva Recent Developments
  13. 8.3 Dechra Veterinary Products
  14. 8.3.1 Dechra Veterinary Products Company Information
  15. 8.3.2 Dechra Veterinary Products Business Overview
  16. 8.3.3 Dechra Veterinary Products Veterinary Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dechra Veterinary Products Veterinary Medicines and Vaccines Product Portfolio
  18. 8.3.5 Dechra Veterinary Products Recent Developments
  19. 8.4 Elanco Animal Health
  20. 8.4.1 Elanco Animal Health Company Information
  21. 8.4.2 Elanco Animal Health Business Overview
  22. 8.4.3 Elanco Animal Health Veterinary Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Elanco Animal Health Veterinary Medicines and Vaccines Product Portfolio
  24. 8.4.5 Elanco Animal Health Recent Developments
  25. 8.5 Meiji
  26. 8.5.1 Meiji Company Information
  27. 8.5.2 Meiji Business Overview
  28. 8.5.3 Meiji Veterinary Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Meiji Veterinary Medicines and Vaccines Product Portfolio
  30. 8.5.5 Meiji Recent Developments
  31. 8.6 Ouro Fino Saude
  32. 8.6.1 Ouro Fino Saude Company Information
  33. 8.6.2 Ouro Fino Saude Business Overview
  34. 8.6.3 Ouro Fino Saude Veterinary Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ouro Fino Saude Veterinary Medicines and Vaccines Product Portfolio
  36. 8.6.5 Ouro Fino Saude Recent Developments
  37. 8.7 Parnell
  38. 8.7.1 Parnell Company Information
  39. 8.7.2 Parnell Business Overview
  40. 8.7.3 Parnell Veterinary Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Parnell Veterinary Medicines and Vaccines Product Portfolio
  42. 8.7.5 Parnell Recent Developments
  43. 8.8 Vetoquinol
  44. 8.8.1 Vetoquinol Company Information
  45. 8.8.2 Vetoquinol Business Overview
  46. 8.8.3 Vetoquinol Veterinary Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Vetoquinol Veterinary Medicines and Vaccines Product Portfolio
  48. 8.8.5 Vetoquinol Recent Developments
  49. 8.9 Virbac
  50. 8.9.1 Virbac Company Information
  51. 8.9.2 Virbac Business Overview
  52. 8.9.3 Virbac Veterinary Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Virbac Veterinary Medicines and Vaccines Product Portfolio
  54. 8.9.5 Virbac Recent Developments
  55. 8.10 Zoetis
  56. 8.10.1 Zoetis Company Information
  57. 8.10.2 Zoetis Business Overview
  58. 8.10.3 Zoetis Veterinary Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Zoetis Veterinary Medicines and Vaccines Product Portfolio
  60. 8.10.5 Zoetis Recent Developments
  61. 8.11 Bayer Animal Health
  62. 8.11.1 Bayer Animal Health Company Information
  63. 8.11.2 Bayer Animal Health Business Overview
  64. 8.11.3 Bayer Animal Health Veterinary Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Bayer Animal Health Veterinary Medicines and Vaccines Product Portfolio
  66. 8.11.5 Bayer Animal Health Recent Developments
  67. 8.12 Merck Animal Health
  68. 8.12.1 Merck Animal Health Company Information
  69. 8.12.2 Merck Animal Health Business Overview
  70. 8.12.3 Merck Animal Health Veterinary Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Merck Animal Health Veterinary Medicines and Vaccines Product Portfolio
  72. 8.12.5 Merck Animal Health Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst